Kelly muses on the search for a cure, and what we have in the meantime.

We had a great time at AADE learning more about what DexCom has in the works—primarily this relates to work toward FDA approval for its fourth-generation continuous...

Powerhouse AADE Educator of the Year Elaine Massaro emphasizes the importance of behavior change and how to do it.

Contrave, a novel weight-loss drug made by Orexigen. In late January, in a surprise move to many in light of the positive FDA Advisory Committee meeting (see New Now...

Ever get the winter blues? If you're like one member of our team, it may be hard to stay motivated and exercise in the winter months. We checked out the new Bayer and...

The JDRF moves forward internationally to advance the artificial pancreas. The JDRF has partnered with a group of European academics and members of industry who are...

Pass the streusel: the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria.

David Simmons, President and General Manager of Pfizer’s Established Products Business Unit, and Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, shake...

Kerri Morrone Sparling reflects on the power of electronic health journaling to improve your own management of diabetes.

When your blood sugar gets too high, don’t you wish you could just filter the sugar out of your blood stream? In fact, along with waste products, the kidneys filter...

We recently wrote an article on a full-featured “detachable” tubeless insulin pump, Medingo’s Solo MicroPump Insulin Delivery System . We had previously mentioned that...

ASP1941 (SGLT2 inhibitor for type 2).

As we wrote in our New Now Next column in diaTribe #25, Dexcom is developing several new continuous glucose monitoring (CGM) technologies, including a fourth-generation...

(S)he said what?!?

Teaching a child with type 1 diabetes the "facts of life"... Jim Hirsch reflects.

At the recent American Association of Diabetes Educators (AADE) conference in San Antonio, Texas, Tandem Diabetes Care unveiled its anticipated new insulin pump, the t:...

Over the past year, several of the world’s largest pharmaceutical companies have expanded their efforts to develop new diabetes therapies and devices. In late December,...

Taking Control of Your Diabetes (TCOYD) is continuing to offer its stellar conference series in 2010. These events – led by renowned endocrinologist, type 1 diabetes...

We recently reviewed three drug candidates for the treatment of obesity – Contrave, lorcaserin, and Qnexa. All three drugs in development: they all have been submitted...

Canagliflozin (SGLT2 inhibitor for type 2)